"Welcome to Midwest Allergy Sinus Asthma, SC, an allergist office with locations in Normal and Springfield, Illinois. The practice’s goal is to provide you with exceptional care through the use of up-to-date technology and advanced medical knowledge. Midwest Allergy Sinus Asthma also believes in fair, compassionate, personalized, and respectful health care for people of all ages, gender expressions, and walks of life. To them, nothing matters more than the health of the community. For your convenience, the practice offers easy appointment scheduling, with flexible and accessible time slots. The practice offers services such as environmental and food allergy testing, allergy action plans, asthma care, sinusitis treatment, immunology, & more."

During the past decade, Sneeze, Wheeze & Itch Associates, LLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 23 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sneeze, Wheeze & Itch Associates, LLC" #1 sponsor was "Meda Pharmaceuticals" with 11 trials, followed by "Aimmune Therapeutics, Inc." with 5 trials sponsored, "Teva Branded Pharmaceutical Products R&D, Inc." with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sneeze, Wheeze & Itch Associates, LLC" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Sneeze, Wheeze & Itch Associates, LLC" are "Atopic Dermatitis" (12 trials), "Asthma" (9 trials), "Peanut Allergy" (7 trials), "Seasonal Allergic Rhinitis" (6 trials) and "Perennial Allergic Rhinitis" (5 trials). Many other conditions were trialed in "Sneeze, Wheeze & Itch Associates, LLC" in a lesser frequency.

Most popular intervention types in "Sneeze, Wheeze & Itch Associates, LLC" are "Drug" (42 trials), "Biological" (15 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "AR101" (4 trials), "Lebrikizumab" (3 trials), "fluticasone propionate" (3 trials) and "0.15% azelastine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sneeze, Wheeze & Itch Associates, LLC" are 57 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sneeze, Wheeze & Itch Associates, LLC". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Sneeze, Wheeze & Itch Associates, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sneeze, Wheeze & Itch Associates, LLC, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".